CT Pancreas Perfusion
NCT00588367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2015-04-15
Summary
1. Pancreatic CT perfusion with a biofeedback breathing belt worn by the participant, and using novel post-processing techniques, is a reliable method which can be used to differentiate between pancreatic cancer, chronic pancreatitis, and autoimmune pancreatitis.
2. Pancreatic CT perfusion can be used to monitor patients undergoing decompression treatment (endoscopic retrograde cholangiopancreatography with stent placement) for painful chronic pancreatitis, and the change in the pancreatic perfusion parameters correlate with the change in the pain parameters (pain scale and analgesic use).
3. Pancreatic CT perfusion parameters can be calculated using surrogate scan data sets at specific time points to replace the continuous scanning.
Conditions
- Pancreatic Ductal Adenocarcinoma
- Chronic Pancreatitis
- Autoimmune Pancreatitis
Interventions
- DEVICE
-
Mayo Interactive Breath Hold Monitor
Biofeedback device
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Naoki Takahashi, M.D. · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- United States
Study Locations
More Related Trials
-
CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer
NCT03012282 ·Status: TERMINATED ·Phase: NA
-
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
NCT03851237 ·Status: COMPLETED ·Phase: PHASE1
-
The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)
NCT05980221 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
NCT03460769 ·Status: RECRUITING
-
Three New Methods for Diagnosing Pancreas Cancer
NCT00259532 ·Status: UNKNOWN ·Phase: NA
-
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
NCT04275557 ·Status: RECRUITING
-
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx
NCT00767273 ·Status: COMPLETED ·Phase: NA
-
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
NCT06305728 ·Status: RECRUITING
-
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
NCT06271291 ·Status: RECRUITING
-
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers
NCT02683824 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection
NCT01094626 ·Status: WITHDRAWN ·Phase: NA
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT03334708 ·Status: RECRUITING
-
Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC
NCT03032913 ·Status: COMPLETED
-
Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?
NCT06582342 ·Status: RECRUITING
-
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
NCT07117045 ·Status: RECRUITING
-
Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice
NCT02277834 ·Status: COMPLETED
-
Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients
NCT01094561 ·Status: COMPLETED ·Phase: NA
-
Pancreatic Cancer Detection Consortium
NCT06388967 ·Status: RECRUITING
-
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
NCT03937453 ·Status: RECRUITING
-
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
NCT01335945 ·Status: TERMINATED ·Phase: PHASE1
-
Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data
NCT05313854 ·Status: UNKNOWN
-
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
NCT03250078 ·Status: RECRUITING
-
Cancer of the Pancreas Screening Study (CAPS 3)
NCT00438906 ·Status: COMPLETED
-
Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis
NCT01845467 ·Status: WITHDRAWN
-
Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency
NCT01094600 ·Status: WITHDRAWN ·Phase: NA